Cambium Bio Limited’s AGM Results and Strategic Moves

Regeneus Ltd. (AU:CMB) has released an update.

Cambium Bio Limited (ASX:CMB) recently held its Annual General Meeting, where several resolutions were passed, including the reappointment of Clinical A/Prof Chandra Bala as a director. The meeting also saw the approval for additional placement capacity and the issuance of up to AUD$5,000,000 worth of shares. These decisions reflect the company’s strategic plans to strengthen its board and expand its financial capabilities.

For further insights into AU:CMB stock, check out TipRanks’ Stock Analysis page.